Molecular findings of nasopharyngeal carcinoma in a European population

Analytical and Quantitative Cytology and Histology

Volumn 33, Issue 6, 2011, Pages 316-322

  Serrano, María Teresa González ^a   Moreno, María José Ríos ^b   Rodríguez, Manuel de Miguel ^b   Casco, Fernando ^c   Galera Ruiz, Hugo ^b   de los Monteros, María Teresa Vargas ^b,d   Sánchez, Inmaculada Trigo ^d   González Cámpora, Ricardo ^b,d   Galera Davidson, Hugo ^b  

^a Infanta Margarita Hospital   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

Author keywords

Cyclin D1; Fluorescence in situ hybridization; Nasopharyngeal carcinoma; P16

Indexed keywords

CYCLIN D1; PROTEIN P16;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; EUROPEAN AMERICAN; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NASOPHARYNX CARCINOMA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ADULT; AGED; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; SPAIN;

EID: 84861009698     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yu MC, Yuan JM: Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 2002;12:421-429
2. Marks JE, Phillips JL, Menck HR: The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma. Cancer 1998;83: 582-588
3. Lo KW, To KF, Huang DP: Focus on nasopharyngeal carcinoma. Cancer Cell 2004;5:423-428
4. Sherr CJ: The Pezcoller lecture: Cancer cell cycles revisited. Cancer Res 2000;60:3689-3695
5. Namazie A, Alavi S, Olopade OI, Paulette G, Aghamohammadi N, Aghamohammadi M, Gornbein JA, Calcaterra TC, Slamon DJ, Wang MB, Srivatsan ES: Cyclin D1 amplification and p16(MTS1/CDK4I) deletion correlate with poor prognosis in head and neck tumors. Laryngoscope 2002;112:472-481
6. Hwang CF, Cho CL, Huang CC, Wang JS, Shih YL, Su CY, Chang HW: Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy. Ann Oncol 2002;13:1246-1251
7. Chou J, Lin YC, Kim J, You L, Xu Z, He B, Jablons DM: Nasopharyngeal carcinoma: Review of the molecular mechanisms of tumorigenesis. Head Neck 2008;30:946-963
8. Hui AB, Or YY, Takano H, Tsang RK, To KF, Guan XY, Sham JS, Hung KW, Lam CN, van Hasselt CA, Kuo WL, Gray JW, Huang DP, Lo KW: Array-based comparative genomic hybridization analysis identified cyclin D1 as a target oncogene at 11q13.3 in nasopharyngeal carcinoma. Cancer Res 2005; 65:8125-8133
9. Sham JST, Choy D: Prognostic factors of nasopharyngeal carcinoma: A review of 759 patients. Br J Radiol 1990;63:51-58
10. Cheng SH, Jian JJ, Tsai SY, Yen KL, Chu NM, Chan KY, Tan TD, Cheng JC, Leu SY, Hsieh CY, Huang AT: Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. Int J Radiat Oncol Biol Phys 2000;48:1323-1330
11. El-Zammar OA, Zhang S, Katzenstein AL: Comparison of FISH, PCR, and immunohistochemistry in assessing EGFR status in lung adenocarcinoma and correlation with clinicopathologic features. Diagn Mol Pathol 2009;18:133-137
12. Dessy E, Rossi E, Berenzi A, Tironi A, Benetti A, Grigolato P: Chromosome 9 instability and alterations of p16 gene in squamous cell carcinoma of the lung and in adjacent normal bronchi: FISH and immunohistochemical study. Histopathology 2008;52:475-482
13. Okami K, Reed AL, Cairns P, Koch WM, Westra WH, Wehage S, Jen J, Sidransky D: Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma. Oncogene 1999;18:3541-3545
14. Lin HS, Berry GJ, Sun Z, Fee WE Jr: Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma. World J Surg Oncol 2006;4:62-68